These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Arsenic trioxide and the growth of human T-cell leukemia virus type I infected T-cell lines. Ishitsuka K, Hanada S, Uozumi K, Utsunomiya A, Arima T. Leuk Lymphoma; 2000 May 01; 37(5-6):649-55. PubMed ID: 11042529 [Abstract] [Full Text] [Related]
3. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. Barata JT, Silva A, Brandao JG, Nadler LM, Cardoso AA, Boussiotis VA. J Exp Med; 2004 Sep 06; 200(5):659-69. PubMed ID: 15353558 [Abstract] [Full Text] [Related]
4. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Banerji L, Glassford J, Lea NC, Thomas NS, Klaus GG, Lam EW. Oncogene; 2001 Nov 01; 20(50):7352-67. PubMed ID: 11704865 [Abstract] [Full Text] [Related]
5. BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression. Parada Y, Banerji L, Glassford J, Lea NC, Collado M, Rivas C, Lewis JL, Gordon MY, Thomas NS, Lam EW. J Biol Chem; 2001 Jun 29; 276(26):23572-80. PubMed ID: 11323429 [Abstract] [Full Text] [Related]
6. Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression. Reichert TE, Nagashima S, Kashii Y, Stanson J, Gao G, Dou QP, Whiteside TL. Oncogene; 2000 Jan 27; 19(4):514-25. PubMed ID: 10698521 [Abstract] [Full Text] [Related]
7. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation. Baldassarre G, Barone MV, Belletti B, Sandomenico C, Bruni P, Spiezia S, Boccia A, Vento MT, Romano A, Pepe S, Fusco A, Viglietto G. Oncogene; 1999 Nov 04; 18(46):6241-51. PubMed ID: 10597222 [Abstract] [Full Text] [Related]
8. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase. Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL. Blood; 2000 Oct 15; 96(8):2746-54. PubMed ID: 11023508 [Abstract] [Full Text] [Related]
9. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases. Greider C, Chattopadhyay A, Parkhurst C, Yang E. Oncogene; 2002 Nov 07; 21(51):7765-75. PubMed ID: 12420213 [Abstract] [Full Text] [Related]
10. Expression of cell cycle regulatory genes in chronic myelogenous leukemia. Iolascon A, Della Ragione F, Giordani L, Serra A, Saglio G, Faienza MF. Haematologica; 1998 Sep 07; 83(9):771-7. PubMed ID: 9825572 [Abstract] [Full Text] [Related]
11. IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL. Barata JT, Boussiotis VA, Yunes JA, Ferrando AA, Moreau LA, Veiga JP, Sallan SE, Look AT, Nadler LM, Cardoso AA. Blood; 2004 Mar 01; 103(5):1891-900. PubMed ID: 14615384 [Abstract] [Full Text] [Related]
12. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. Appleman LJ, van Puijenbroek AA, Shu KM, Nadler LM, Boussiotis VA. J Immunol; 2002 Mar 15; 168(6):2729-36. PubMed ID: 11884439 [Abstract] [Full Text] [Related]
13. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology]. Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J. Cancer Radiother; 2001 Apr 15; 5(2):109-29. PubMed ID: 11355576 [Abstract] [Full Text] [Related]
14. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells. Cereseto A, Washington Parks R, Rivadeneira E, Franchini G. Oncogene; 1999 Apr 15; 18(15):2441-50. PubMed ID: 10229195 [Abstract] [Full Text] [Related]
15. Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia. Karawajew L, Ruppert V, Wuchter C, Kösser A, Schrappe M, Dörken B, Ludwig WD. Blood; 2000 Jul 01; 96(1):297-306. PubMed ID: 10891465 [Abstract] [Full Text] [Related]
16. Diversity of the apoptotic response to chemotherapy in childhood leukemia. Liu T, Raetz E, Moos PJ, Perkins SL, Bruggers CS, Smith F, Carroll WL. Leukemia; 2002 Feb 01; 16(2):223-32. PubMed ID: 11840289 [Abstract] [Full Text] [Related]
17. 4-1BB enhances CD8+ T cell expansion by regulating cell cycle progression through changes in expression of cyclins D and E and cyclin-dependent kinase inhibitor p27kip1. Lee HW, Nam KO, Park SJ, Kwon BS. Eur J Immunol; 2003 Aug 01; 33(8):2133-41. PubMed ID: 12884287 [Abstract] [Full Text] [Related]
18. Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta. Hu X, Zuckerman KS. Leuk Lymphoma; 2000 Jul 01; 38(3-4):235-46. PubMed ID: 10830731 [Abstract] [Full Text] [Related]
19. The CDK inhibitor, p27Kip1, is required for IL-4 regulation of astrocyte proliferation. Liu J, Flanagan WM, Drazba JA, Estes ML, Barnett GH, Haqqi T, Kondo S, Barna BP. J Immunol; 1997 Jul 15; 159(2):812-9. PubMed ID: 9218599 [Abstract] [Full Text] [Related]
20. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T. J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912 [Abstract] [Full Text] [Related] Page: [Next] [New Search]